Mark R. Bowlby - Concepedia

Author

Mark R. Bowlby

Also Known As

Bowlby, Mark, M R Bowlby, M. Bowlby, M. R. Bowlby, M.R BOWLBY, M.R. Bowlby, MARK R. BOWLBY, Mark Bowlby, Mark R Bowlby, Mark R. Bowlby

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Princeton University University of California, Santa Barbara Women's Health Research Institute Brandeis University United States Military Academy

About

Mark R. Bowlby is an author at Princeton University specializing in medicine, neurophysiology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.9K
2	Social Sciences	11	11	1.4K
3	Engineering	4	4	100
4	Natural Sciences	3	3	92
5	Health Sciences	2	2	57

Mark R. Bowlby

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Modulation of A-type potassium channels by a family of calcium sensors Wei An, Mark R. Bowlby, Maria Betty, Nature Calcium SensorsHyperpolarization (Biology)NeurophysiologyPhysiologyBioelectronics	2000	965
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease J. Steven Jacobsen, Chi-Cheng Wu, Jeffrey M. Redwine, Proceedings of the National Academy of Sciences	2006	699
Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics Seongeun Cho, Andrew Wood, Mark R. Bowlby Current Neuropharmacology	2007	241
Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mark R. Bowlby Molecular Pharmacology	1993	229
Remodelling inactivation gating of Kv4 channels by KChIP1, a small‐molecular‐weight calcium‐binding protein Edward J. Beck, Mark R. Bowlby, Wei An, The Journal of Physiology	2002	136
Modulation of the Kv1.3 Potassium Channel by Receptor Tyrosine Kinases Mark R. Bowlby, Debra Ann Fadool, Todd C. Holmes, The Journal of General Physiology	1997	122
Amiloride is neuroprotective in an MPTP model of Parkinson's disease Robert L. Arias, Mei-Li Amy Sung, Dmytro V. Vasylyev, Neurobiology of Disease Mptp ModelMedicineNeuropharmacologyNeurochemical BiomarkersPharmacotherapy	2008	119
Two N-Terminal Domains of Kv4 K+ Channels Regulate Binding to and Modulation by KChIP1 Robert H. Scannevin, KeWei Wang, Flora Jow, Neuron Molecular NeuroscienceMolecular PhysiologySignal TransductionHyperpolarization (Biology)N-terminal Domains	2004	117
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities Benfang Helen Ruan, Kevin Pong, Flora Jow, Proceedings of the National Academy of Sciences Immunophilin LigandsCell DeathSynaptic SignalingNeuroinflammationMolecular Pharmacology	2007	111
Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition Jason M. Uslaner, Spencer J. Tye, Donnie Eddins, Science Translational Medicine Sleep DisordersCurrent TreatmentsPsychotropic MedicationReceptor AntagonistsPharmacotherapy	2013	89

Page 1